Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Valentin Le Douce, Amina Ait-Amar, Faezeh Forouzan far, Faiza Fahmi, Jose Quiel, Hala El Mekdad, Fadoua Daouad, Céline Marban, Olivier Rohr & Christian Schwartz. (2016) Improving combination antiretroviral therapy by targeting HIV-1 gene transcription. Expert Opinion on Therapeutic Targets 20:11, pages 1311-1324.
Read now
Read now
Articles from other publishers (39)
Mengyuan Lyu, Hongli Lai, Yili Wang, Yanbing Zhou, Yi Chen, Dongsheng WuJie Chen & Binwu Ying. (2023) Roles of alternative splicing in infectious diseases: from hosts, pathogens to their interactions. Chinese Medical Journal 136:7, pages 767-779.
Crossref
Crossref
Ruba H. Ghanam, Gunnar N. Eastep & Jamil S. Saad. (2023) Structural Insights into the Mechanism of HIV-1 Tat Secretion from the Plasma Membrane. Journal of Molecular Biology 435:2, pages 167880.
Crossref
Crossref
Magan Solomon & Chen Liang. 2023. Pseudotyped Viruses. Pseudotyped Viruses
61
84
.
Beibei Lou, Yanfei Liu, Meilin Shi, Jun Chen, Ke Li, Yifu Tan, Liwei Chen, Yuwei Wu, Ting Wang, Xiaoqin Liu, Ting Jiang, Dongming Peng & Zhenbao Liu. (2022) Aptamer-based biosensors for virus protein detection. TrAC Trends in Analytical Chemistry 157, pages 116738.
Crossref
Crossref
Malini Menon, Roli Budhwar, Rohit Nandan Shukla, Kiran Bankar, Madavan Vasudevan & Udaykumar Ranga. (2020) The Signature Amino Acid Residue Serine 31 of HIV-1C Tat Potentiates an Activated Phenotype in Endothelial Cells. Frontiers in Immunology 11.
Crossref
Crossref
Elmostafa Bahraoui, Manutea Serrero & Rémi Planès. (2020) HIV-1 Tat – TLR4/MD2 interaction drives the expression of IDO-1 in monocytes derived dendritic cells through NF-κB dependent pathway. Scientific Reports 10:1.
Crossref
Crossref
Seyoun Byun, Seonggyun Han, Yue Zheng, Vicente Planelles & Younghee Lee. (2020) The landscape of alternative splicing in HIV-1 infected CD4 T-cells. BMC Medical Genomics 13:S5.
Crossref
Crossref
Samira Alipour & Atiyeh Mahdavi. (2020) Boosting Tat DNA vaccine with Tat protein stimulates strong cellular and humoral immune responses in mice. Biotechnology Letters.
Crossref
Crossref
M.F. Fatin, A. Rahim Ruslinda, Subash C.B. Gopinath & M.K.Md. Arshad. (2019) High-performance interactive analysis of split aptamer and HIV-1 Tat on multiwall carbon nanotube-modified field-effect transistor. International Journal of Biological Macromolecules 125, pages 414-422.
Crossref
Crossref
Munindra Ruwali & Rahul Shukla. 2019. Pathogenicity and Drug Resistance of Human Pathogens. Pathogenicity and Drug Resistance of Human Pathogens
317
335
.
Min Liu, Xin Du & Jun Zhou. (2018) Non-canonical function of Tat in regulating host microtubule dynamics: Implications for the pathogenesis of lentiviral infections. Pharmacology & Therapeutics 182, pages 28-32.
Crossref
Crossref
Lina Rustanti, Hongping Jin, Mary Lor, Min Hsuan Lin, Daniel J. Rawle & David Harrich. (2017) A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes. Virology Journal 14:1.
Crossref
Crossref
Samira Alipour, Atiyeh Mahdavi & Asghar Abdoli. (2017) The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat-based candidate vaccines in mice. Pathogens and Disease 75:2.
Crossref
Crossref
Burger Symington, Rudo F. Mapanga, Gavin R. Norton & M. Faadiel Essop. (2017) Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration. PLOS ONE 12:1, pages e0170344.
Crossref
Crossref
Vu To, Edis Dzananovic, Sean A. McKenna & Joe O’Neil. (2016) The Dynamic Landscape of the Full-Length HIV-1 Transactivator of Transcription. Biochemistry 55:9, pages 1314-1325.
Crossref
Crossref
Clarke Brian Blackadar. (2016) Historical review of the causes of cancer. World Journal of Clinical Oncology 7:1, pages 54.
Crossref
Crossref
Ferdous Kadri, Marco Pacifici, Anna Wilk, Amanda Parker-Struckhoff, Luis Del Valle, Kurt F. Hauser, Pamela E. Knapp, Christopher Parsons, Duane Jeansonne, Adam Lassak & Francesca Peruzzi. (2015) HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase. Journal of Biological Chemistry 290:52, pages 30931-30946.
Crossref
Crossref
Ruqiang Xu, Nazira El-Hage & Seth M. Dever. (2015) Fluorescently-labeled RNA packaging into HIV-1 particles: Direct examination of infectivity across central nervous system cell types. Journal of Virological Methods 224, pages 20-29.
Crossref
Crossref
Gi Soo Youn, Sung Mi Ju, Soo Young Choi & Jinseu Park. (2015) HDAC6 mediates HIV-1 tat-induced proinflammatory responses by regulating MAPK-NF-kappaB/AP-1 pathways in astrocytes. Glia 63:11, pages 1953-1965.
Crossref
Crossref
Manish Kumar Johri, Nikhil Sharma & Sunit K. Singh. (2015) HIV Tat protein: Is Tat-C much trickier than Tat-B?. Journal of Medical Virology 87:8, pages 1334-1343.
Crossref
Crossref
Nawal Ben Haij, Rémi Planès, Kaoutar Leghmari, Manutea Serrero, Pierre Delobel, Jacques Izopet, Lbachir BenMohamed & Elmostafa Bahraoui. (2015) HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway. PLOS ONE 10:6, pages e0129425.
Crossref
Crossref
Sophie Sagnier, Coralie F. Daussy, Sophie Borel, Véronique Robert-Hebmann, Mathias Faure, Fabien P. Blanchet, Bruno Beaumelle, Martine Biard-Piechaczyk & Lucile Espert. (2015)
Autophagy Restricts HIV-1 Infection by Selectively Degrading Tat in CD4
+
T Lymphocytes
. Journal of Virology 89:1, pages 615-625.
Crossref
Crossref
Guillaume Mousseau, Sonia Mediouni & Susana T. Valente. 2015. The Future of HIV-1 Therapeutics. The Future of HIV-1 Therapeutics
121
145
.
Gi Soo Youn, Dong-Joo Kwon, Sung Mi Ju, Hyangshuk Rhim, Yong Soo Bae, Soo Young Choi & Jinseu Park. (2014) Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes. Toxicology and Applied Pharmacology 280:1, pages 42-52.
Crossref
Crossref
Kristopher Montrose, Yi Yang & Geoffrey W. Krissansen. (2014) X-pep, a novel cell-penetrating peptide motif derived from the hepatitis B virus. Biochemical and Biophysical Research Communications 453:1, pages 64-68.
Crossref
Crossref
R. Planes, L. BenMohamed, K. Leghmari, P. Delobel, J. Izopet & E. Bahraoui. (2014) HIV-1 Tat Protein Induces PD-L1 (B7-H1) Expression on Dendritic Cells through Tumor Necrosis Factor Alpha- and Toll-Like Receptor 4-Mediated Mechanisms. Journal of Virology 88:12, pages 6672-6689.
Crossref
Crossref
S.A. Spector. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Haran Sivakumaran, Min-Hsuan Lin, Ann Apolloni, Vincent Cutillas, Hongping Jin, Dongsheng Li, Ting Wei & David Harrich. (2013) Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. Virology Journal 10:1.
Crossref
Crossref
Santosh Kumar & Souvik Maiti. (2013) The Effect of N-acetylation and N-methylation of Lysine Residue of Tat Peptide on its Interaction with HIV-1 TAR RNA. PLoS ONE 8:10, pages e77595.
Crossref
Crossref
Mitesh Patel, Nanda K Mandava, Ramya Krishna Vadlapatla & Ashim K Mitra. (2013) Recent patents and emerging therapeutics for HIV infections: a focus on protease inhibitors. Pharmaceutical Patent Analyst 2:4, pages 513-538.
Crossref
Crossref
Alberto Minassi, Gonzalo Sánchez-Duffhues, Juan Antonio Collado, Eduardo Muñoz & Giovanni Appendino. (2013) Dissecting the Pharmacophore of Curcumin. Which Structural Element Is Critical for Which Action?. Journal of Natural Products 76:6, pages 1105-1112.
Crossref
Crossref
Kristopher Montrose, Yi Yang, Xueying Sun, Siouxsie Wiles & Geoffrey W. Krissansen. (2013) Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs. Scientific Reports 3:1.
Crossref
Crossref
Aaron Brice & Gregory W Moseley. (2013) Viral interactions with microtubules: orchestrators of host cell biology?. Future Virology 8:3, pages 229-243.
Crossref
Crossref
Ritu Mishra & Sunit Singh. 2013. Neuroviral Infections. Neuroviral Infections
457
484
.
Yunyun Yuan, Christopher K. Arnatt, Nazira El-Hage, Seth M. Dever, Joanna C. Jacob, Dana E. Selley, Kurt F. Hauser & Yan Zhang. (2013) A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimer: binding affinity versus functional activities. MedChemComm 4:5, pages 847.
Crossref
Crossref
Vo Cam Quy, Sergio Pantano, Giulia Rossetti, Mauro Giacca & Paolo Carloni. (2012) HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods. Biology 1:2, pages 277-296.
Crossref
Crossref
Giulia Marsili, Anna Lisa Remoli, Marco Sgarbanti, Edvige Perrotti, Alessandra Fragale & Angela Battistini. (2012) HIV-1, interferon and the interferon regulatory factor system: An interplay between induction, antiviral responses and viral evasion. Cytokine & Growth Factor Reviews 23:4-5, pages 255-270.
Crossref
Crossref
Hong-Sheng Zhang, Tong-Chao Wu, Wei-Wei Sang & Zheng Ruan. (2012) MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:5, pages 1017-1023.
Crossref
Crossref
Johanie Charbonneau, Karine Gendron, Gerardo Ferbeyre & Léa Brakier-Gingras. (2012) The 5′ UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed −1 ribosomal frameshift that generates HIV-1 enzymes. RNA 18:3, pages 519-529.
Crossref
Crossref